These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8573324)

  • 1. Erythropoietin--improving the quality of life of dialysis patients.
    Kionka C
    J Biotechnol; 1995 Nov; 43(1):73-4. PubMed ID: 8573324
    [No Abstract]   [Full Text] [Related]  

  • 2. [The development and clinical application of erythropoietin].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1521-7. PubMed ID: 1761935
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of anemia in oncology. Introduction.
    Adamson JW
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):1-2. PubMed ID: 1615333
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].
    Fandrey JK; Jelkmann WE
    Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis.
    Grützmacher P; Bergmann M; Weinreich T; Nattermann U; Reimers E; Pollok M
    Contrib Nephrol; 1988; 66():104-13. PubMed ID: 3292143
    [No Abstract]   [Full Text] [Related]  

  • 7. The application of recombinant erythropoietin in anemic patients with cancer.
    Spivak JL
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):25-8. PubMed ID: 1615336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of renal anaemia by recombinant human erythropoietin: effects on myocardial function.
    Grützmacher P; Scheuermann E; Löw I; Bergmann M; Rauber K; Baum R; Heuser J; Schoeppe W
    Contrib Nephrol; 1988; 66():176-84. PubMed ID: 3292146
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of XBP-1 signaling during transient and stable recombinant protein production in CHO cells.
    Ku SC; Toh PC; Lee YY; Chusainow J; Yap MG; Chao SH
    Biotechnol Prog; 2010; 26(2):517-26. PubMed ID: 19938059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia management in dialysis: Why the FDA and CMS have it right (and how KDIGO got it wrong).
    Coyne DW
    Nephrol News Issues; 2013 Feb; 27(2):16, 18, 20. PubMed ID: 23469454
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin in anemia of prematurity.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):80-4. PubMed ID: 23025776
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin.
    Bommer J; Huber W; Tewes G; Ritz E; von Wedel S; Küppers S; Weinreich T; Bommer G
    Contrib Nephrol; 1988; 66():131-8. PubMed ID: 3391027
    [No Abstract]   [Full Text] [Related]  

  • 14. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.
    Thomas ML
    Med Oncol; 1998 Aug; 15 Suppl 1():S13-8. PubMed ID: 9785332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure changes during treatment with recombinant human erythropoietin.
    Samtleben W; Baldamus CA; Bommer J; Fassbinder W; Nonnast-Daniel B; Gurland HJ
    Contrib Nephrol; 1988; 66():114-22. PubMed ID: 3292144
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant growth factors.
    Goodnough LT; Anderson KC
    Transfus Sci; 1995 Mar; 16(1):45-62. PubMed ID: 10155704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin.
    Erslev AJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):14-8. PubMed ID: 1615334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant hCG (OVIDREL) and recombinant interferon-(beta)1a (REBIF). (No. 13 in a series of articles to promote a better understanding of the use of genetic engineering).
    Fonjallaz P; Loumaye E
    J Biotechnol; 2001 May; 87(3):279-81. PubMed ID: 11411454
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of using human recombinant erythropoietin in a patient treated by peritoneal dialysis complicated by chronic infection of the tunnel of the dialysis catheter].
    Wanic-Kossowska M; Grzegorzewska A; Piszczek I; Krzymański M
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):694-5. PubMed ID: 1492040
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant human erythropoietin--its potential in the perisurgical setting.
    Shane A
    Oncology (Williston Park); 1991 Jun; 5(6):56, 58, 60. PubMed ID: 1831640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.